MT1013

· Shaanxi Micot Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MT1013, covering 2025-10-01 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism [Phase 2]

See pricing